Molecular basis for receptor tyrosine kinase A-loop tyrosine transphosphorylation

Lingfeng Chen1,2,3, William M Marsiglia4, Huaibin Chen2

  • 1School of Chemical Engineering, Nanjing University of Science and Technology, Nanjing, China.

Nature Chemical Biology
|January 22, 2020
PubMed

Insights

Receptor tyrosine kinase transphosphorylation occurs via an unstable asymmetric complex. Ligand binding stabilizes this complex, enabling kinase activation and signaling, with mutations impacting stability and activity.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Cell Signaling

Background:

  • Receptor tyrosine kinases (RTKs) regulate crucial cellular processes.
  • The mechanism of transphosphorylation, particularly of activation loop (A-loop) tyrosines in catalytically repressed RTKs, remains poorly understood.
  • Understanding RTK activation is vital for deciphering signaling pathways and disease mechanisms.

Purpose of the Study:

  • To elucidate the mechanism of A-loop tyrosine transphosphorylation in RTKs.
  • To investigate the role of complex formation and electrostatic interactions in RTK activation.
  • To understand how mutations affect RTK activity and signaling.

Main Methods:

  • Biochemical assays to study kinase complex formation and activity.
  • Analysis of electrostatic interactions between enzyme and substrate kinases.
  • Investigating the impact of a pathogenic fibroblast growth factor receptor (FGFR) mutation on complex stability and phosphorylation.

Main Results:

  • RTK transphosphorylation proceeds through a thermodynamically disadvantaged asymmetric complex due to electrostatic repulsion.
  • Ligand-induced dimerization of extracellular domains stabilizes the transphosphorylating dimer under physiological conditions.
  • A pathogenic FGFR mutation enhances complex formation by eliminating repulsive forces, leading to increased A-loop phosphorylation and kinase activity.

Conclusions:

  • Asymmetric complex formation is crucial for A-loop tyrosine phosphorylation and RTK activation.
  • The stability of extracellular dimerization dictates the extent of intracellular asymmetric complex formation and kinase activity.
  • This mechanism explains how RTK signaling intensity is modulated and how specific mutations can lead to aberrant signaling.

Related Concept Videos

Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
17.5K
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
85.4K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
3.7K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
16.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K